225 related articles for article (PubMed ID: 9045618)
1. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis.
Xiao GH; Shoarinejad F; Jin F; Golemis EA; Yeung RS
J Biol Chem; 1997 Mar; 272(10):6097-100. PubMed ID: 9045618
[TBL] [Abstract][Full Text] [Related]
2. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
[TBL] [Abstract][Full Text] [Related]
3. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.
Wienecke R; König A; DeClue JE
J Biol Chem; 1995 Jul; 270(27):16409-14. PubMed ID: 7608212
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
[TBL] [Abstract][Full Text] [Related]
5. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.
van Slegtenhorst M; Nellist M; Nagelkerken B; Cheadle J; Snell R; van den Ouweland A; Reuser A; Sampson J; Halley D; van der Sluijs P
Hum Mol Genet; 1998 Jun; 7(6):1053-7. PubMed ID: 9580671
[TBL] [Abstract][Full Text] [Related]
6. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.
Soucek T; Pusch O; Wienecke R; DeClue JE; Hengstschläger M
J Biol Chem; 1997 Nov; 272(46):29301-8. PubMed ID: 9361010
[TBL] [Abstract][Full Text] [Related]
7. Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin.
Yamamoto Y; Jones KA; Mak BC; Muehlenbachs A; Yeung RS
Arch Biochem Biophys; 2002 Aug; 404(2):210-7. PubMed ID: 12147258
[TBL] [Abstract][Full Text] [Related]
8. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
[TBL] [Abstract][Full Text] [Related]
9. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
Aicher LD; Campbell JS; Yeung RS
J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
[TBL] [Abstract][Full Text] [Related]
10. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin.
Nellist M; van Slegtenhorst MA; Goedbloed M; van den Ouweland AM; Halley DJ; van der Sluijs P
J Biol Chem; 1999 Dec; 274(50):35647-52. PubMed ID: 10585443
[TBL] [Abstract][Full Text] [Related]
12. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
Miloloza A; Kubista M; Rosner M; Hengstschläger M
J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex: genetics to pathogenesis.
Narayanan V
Pediatr Neurol; 2003 Nov; 29(5):404-9. PubMed ID: 14684235
[TBL] [Abstract][Full Text] [Related]
14. Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis.
Zech R; Kiontke S; Mueller U; Oeckinghaus A; Kümmel D
J Biol Chem; 2016 Sep; 291(38):20008-20. PubMed ID: 27493206
[TBL] [Abstract][Full Text] [Related]
15. The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
Mak BC; Takemaru K; Kenerson HL; Moon RT; Yeung RS
J Biol Chem; 2003 Feb; 278(8):5947-51. PubMed ID: 12511557
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish.
Maheshwar MM; Sandford R; Nellist M; Cheadle JP; Sgotto B; Vaudin M; Sampson JR
Hum Mol Genet; 1996 Jan; 5(1):131-7. PubMed ID: 8789450
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin.
Lu Z; Hu X; Li Y; Zheng L; Zhou Y; Jiang H; Ning T; Basang Z; Zhang C; Ke Y
J Biol Chem; 2004 Aug; 279(34):35664-70. PubMed ID: 15175323
[TBL] [Abstract][Full Text] [Related]
18. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
[TBL] [Abstract][Full Text] [Related]
19. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
[TBL] [Abstract][Full Text] [Related]
20. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
